Primary Thrombocytopenia
1 clinical trials · Condition
◉ Watch Primary Thrombocytopenia
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia (NCT01349790) | Octapharma | 2011-10-01 |
Track Primary Thrombocytopenia automatically
Every clearance here is in the API, with alerts when new ones post.